Elizabeth Repash

Statistics

Publications

Citations

102

H-Index

Active since

2021

Affiliations

Bicycle Therapeutics (United Kingdom)(Current)

Elizabeth Repash is an author at Bicycle Therapeutics (United Kingdom) specializing in cancer immunology, medicinal chemistry, and bicyclic peptide design.

Publications per year

2021–2022

Publications

BT7480, a novel fully synthetic <i>Bicycle</i> tumor-targeted immune cell agonist™ (<i>Bicycle</i> TICA™) induces tumor localized CD137 agonism

Kristen E. Hurov, Johanna Lahdenranta, Punit Upadhyaya et al. · Journal for ImmunoTherapy of Cancer · 2021 · 37 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist

Punit Upadhyaya, Johanna Lahdenranta, Kristen E. Hurov et al. · Journal for ImmunoTherapy of Cancer · 2021 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology

Punit Upadhyaya, Julia Kristensson, Johanna Lahdenranta et al. · Journal of Medicinal Chemistry · 2022 · 19 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Solving the Problem of Assessing Synergy and Antagonism for Non-Traditional Dosing Curve Compounds Using the DE/ZI Method: Application to Nrf2 Activators

Elizabeth Repash, Kaitlin Pensabene, Peter M. Palenchar et al. · Frontiers in Pharmacology · 2021 · 14 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

1–4 of 4